• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Mental Health Support

A diagnosis of ALS/MND affects emotional health as well as physical health. People living with ALS/MND and their families can face strong and changing emotions at every stage of the disease. These reactions are normal, and support is available.

This page explains common emotional responses, when to ask for help, the treatments and support available, and changes to thinking and behaviour that some people experience.

On this page

Emotional responses  │  When to ask for help  │  Treatment and support  │  Emotional lability  │  Thinking and behaviour  │  Family and caregivers  │  Resources

Common emotional responses

People living with ALS/MND and those close to them often experience:

  • Shock, disbelief, or numbness after diagnosis
  • Grief for losses, both now and in the future
  • Anxiety and worry about what lies ahead
  • Low mood, sadness, or anger
  • Frustration as abilities change
  • Strain on relationships, roles, and identity

These feelings can come and go, and they often return when the disease changes or a new decision needs to be made.

When to ask for help

Talk to your doctor or care team if you or someone close to you has:

  • Low mood or loss of interest in things you usually enjoy, lasting two weeks or more
  • Worry or anxiety that is hard to control or interferes with daily life
  • Feelings of hopelessness or being a burden
  • Difficulty coping with daily life or relationships

Depression and anxiety are treatable, even when they are linked to a serious illness. Asking for help early makes a difference.

If you are thinking about harming yourself, or feel unable to keep yourself safe, contact your local emergency services or a crisis line in your country immediately.

Treatment and support

Different types of support suit different people and needs:

  • Talking therapies, such as counselling and psychotherapy, help people work through difficult emotions, adjust to change, and develop ways of coping.
  • Medication can treat depression and anxiety. A doctor can advise whether medication is suitable, taking other treatments and symptoms into account.
  • Peer support from others living with ALS/MND, through support groups or online communities, can reduce isolation.
  • Practical support from a social worker with finances, care arrangements, and services can ease stress for the whole family.

Emotional lability

Some people with ALS/MND experience sudden laughing or crying that is out of proportion to how they feel, or that they cannot control. This is called emotional lability (also known as pseudobulbar affect).

It is caused by the effect of ALS/MND on the brain, not by a person’s mood or character. It can be embarrassing or distressing, but it can be treated. Tell the care team if it happens.

Changes in thinking and behaviour

Some people with ALS/MND experience changes in thinking, language, or behaviour. These changes are often mild, such as difficulty planning, concentrating, or finding words. A smaller number of people develop frontotemporal dementia (FTD): a type of dementia that affects the front and sides of the brain and changes personality, behaviour, and language.

Changes in thinking and behaviour can be difficult for families to recognize and understand. A neuropsychologist or the care team can assess these changes and suggest ways to manage them.

Support for family and caregivers

Family members and caregivers need emotional support too. Many of the professionals and services on this page are also available to them. See Support for Family and Caregivers.

Who can help

  • Family doctor (general practitioner): a first point of contact for mood and anxiety, and for referrals
  • Psychologist or counsellor: provides talking therapies
  • Psychiatrist: diagnoses and treats mental health conditions, including with medication
  • Neuropsychologist: assesses changes in thinking and behaviour
  • Social worker: offers emotional and practical support and connects families with services
  • Spiritual or faith counsellor: offers support with questions of meaning, faith, and values
  • Occupational therapist: helps people stay engaged in activities that matter to them

Services vary between countries. Your ALS/MND clinic or local ALS/MND association can help you find support near you.

Videos about mental health and emotional support

Watch videos about mental health, emotional wellbeing, and support for people living with ALS/MND and their families.

Watch the video playlist →


Resources from our members

Explore additional resources about emotional wellbeing, mental health support, and changes in thinking and behaviour developed by Alliance member associations.

Emotional and psychological support

Emotional and Psychological Support

MND Association · English

A guide to recognizing difficult emotions, finding support, and understanding the therapies available for people living with MND and their caregivers.

View resource →

Coping with ALS

The ALS Association · English

Information about signs that a person may need mental health support, and the treatment and support options available.

View resource →

What Does the Psychologist Do?

ALS Centrum Nederland · Dutch

An overview of the psychologist’s role on the care team and the support a psychologist can offer people living with ALS/MND, their caregivers, and families.

View resource →

What Can the Social Worker Do for You?

ALS Centrum Nederland · Dutch and English

Information about the social worker’s role and the emotional and practical support they offer people living with ALS/MND and their families.

View resource →

Psychological Treatment Program

ALS Society of British Columbia · English · British Columbia, Canada

Therapy and counselling from psychologists and registered clinical counsellors trained in ALS. The service is free for people without extended health benefits and is available in British Columbia only.

View resource →

Changes in thinking and behaviour

Changes to Thinking and Behaviour with MND

MND Association · English

Information about changes to thinking and behaviour that some people with MND experience, with guidance for people living with MND, their caregivers, and families.

View resource →

Changes in Thinking and Emotional Lability

The ALS Association · English

Information about changes in thinking, dementia, depression, and emotional lability, and how people living with ALS/MND and caregivers can manage them.

View resource →

ALS, Cognitive Impairment and Dementia

The ALS Association · English · For health professionals

A fact sheet about cognitive change and frontotemporal dementia in ALS/MND, how to manage these changes, and how to discuss them with people living with ALS/MND.

View resource →

Primary Sidebar

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

  • Hollister

    Hollister
    hollister

  • John Sweeney, USA

    John Sweeney, USA

  • Purningam Jacob, India

    Purningam Jacob, India

  • Paul Launer, USA

    Paul Launer, USA

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • John Dinon, Australia

    John Dinon, Australia

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Ian Gale, Australia

    Ian Gale, Australia

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • David Solomon, UK

    David Solomon, UK

  • JP

    JP

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Liam Dwyer, England

    Liam Dwyer, England

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Susan Keldani, USA

    Susan Keldani, USA

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Denis Blais, Canada

    Denis Blais, Canada

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Willi Klein, UK

    Willi Klein, UK

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Zabun Nassar, England

    Zabun Nassar, England

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Olga, Argentina

    Olga, Argentina

  • Jay Epstein, USA

    Jay Epstein, USA

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login